SBM Life Science, the group behind the iconic fertiliser brands, Baby Bio® and Phostrogen®, has celebrated a successful season for the company, sharing news of the expansion of its UK sales team and the growth of market shares throughout 2022.
Bolstering its brands’ presence across the south-west of England, the group has announced the appointment of a new partnership with JBM Sales Ltd, increasing the SBM sales representatives throughout the region with an additional three team members. Led by directors James Mitchell and Becky Rose, and supported by Tara Truman, the team brings a wealth of experience to the accounts, having previously worked across key industry names such as Westland, Doff and Sinclair.
James Mitchell, director at JBM Sales Ltd, said: “We are incredibly excited to begin working with SBM Life Science across the south-west of England. Together, we have a shared aim and ambition to increase the penetration throughout the region by offering excellent service coupled with an innovative portfolio.”
Scott Williams, UK Sales Director for SBM Life Science, added: “We are delighted to welcome, James, Becky and Tara to the growing SBM team, increasing our sales representation in the area significantly, which will enable us to further our exposure and achieve even greater market growth throughout next season.”
The appointment of JBM Sales Ltd comes as GfK Market Data released for the period July 2021-June 22 reveals that SBM’s UK market shares in plant fertilisers has grown by 4%, despite an overall market decline of -14%, following the launch of a new range of organic fertilisers earlier this year for the much-loved plant food brand, Phostrogen®.
Having also introduced a new Organic Houseplant Food to Baby Bio®’s extensive portfolio, GfK Market Data also reports that the group’s market share in houseplant care has increased by 5% during the same period, maintaining the brand’s position as the leading name for houseplant care products, while its share in plant insecticides has also grown by 5%.
The success follows a significant investment in marketing activity at the beginning of the season, implemented to stimulate growth and support the new product launches. Activity has included a fresh rebrand for Phostrogen®, the launch of a digital campaign, including the broadcast of the brand’s first television advert, appointment of gardening specialist PR agency Honest Communications, and a host of innovative instore creative and point of sale solutions.
James Ramnought, Marketing Director for SBM Life Science commented: “Despite challenging conditions in the market over the past year, we are delighted with the increase in shares achieved this season. This continued growth demonstrates the belief our retail partners and consumers have in the brands, the products, and our future strategy, and we look forward to progressing plans for a successful 2023 season.”
For more information about SBM Life Science, please visit www.solabiol.com/en